The Office of Management and Budget published a sweeping proposed rule last week that would require senior political appointees at every federal agency to review and approve all discretionary grants before they are awarded — a change that would subject billions of dollars in scientific research funding to political oversight at a level without modern precedent.
The 412-page rule, published in the Federal Register on May 29 under docket OMB-2026-0034, covers every federal agency and department that distributes funds — from science agencies including the National Institutes of Health and the National Science Foundation to the Department of Homeland Security, the Commerce Department, and the Peace Corps. Under the proposed rule, a political appointee designated as a “senior official” at each agency would be required to conduct a “pre-issuance review” of every discretionary grant and sign off before any award can be made.
The rule states explicitly that these appointees are forbidden from deferring to peer reviewers or routinely ratifying the recommendations of career program officers. Peer review — the independent scientific evaluation process that has governed research grant awards for more than 70 years — would not be eliminated, but would be reduced from a decision-making mechanism to an advisory input. The final word would belong to the political appointee.
The public comment period closes July 13. If finalized as written, the rule would take effect October 1, 2026, governing all federal grant awards in fiscal year 2027.
What the Rule Specifies
The rule’s requirements go beyond the basic shift in approval authority. The criteria that political appointees must apply when reviewing grants include blocking awards that touch on what the rule characterizes as the “denial of the sex binary in humans,” research related to illegal immigration, or anything deemed to “promote anti-American values.”
International scientific collaborations would face a wide prohibition. The rule would bar federal agencies from funding research that involves foreign institutions in ways the rule defines as potentially compromising national security or program integrity — a formulation broad enough to affect collaborative work with universities and labs in allied nations that has historically been a core feature of federally funded research.
The rule would also eliminate federal support for open-access publishing fees, a funding stream that has helped make American research findings publicly accessible without cost to readers. Researchers who receive NIH, NSF, or other agency grants have often used grant funds to cover article processing charges at open-access journals — a cost that would no longer be eligible under the proposed rule.
The combined effect, science policy analysts say, would be to concentrate decision-making authority about what research gets done in the hands of officials who are not necessarily scientists, are not subject to the expertise requirements of peer review panels, and serve at the pleasure of the administration.
The Scale of What’s at Stake
NIH alone distributes approximately $50 billion in research grants annually, funding work at universities, hospitals, and research institutions across the country. That funding supports basic and applied research in cancer, heart disease, Alzheimer’s, infectious disease, mental health, and dozens of other medical fields. NSF distributes roughly $8 billion per year, funding research in physics, chemistry, computer science, engineering, environmental science, and the social sciences.
Across all federal agencies, the United States government funds more than $150 billion in research and development annually, the largest public research funding system in the world. That investment, built over decades, underlies the U.S. position in pharmaceutical development, defense technology, semiconductor manufacturing, and a range of fields where American companies and institutions compete globally.
The peer review system was designed to make funding decisions on scientific merit — not agency priority, political compatibility, or the preferences of any particular administration. Career program officers and external peer reviewers who hold relevant expertise evaluate proposals against technical and scientific criteria. That structure is intended to insulate the allocation of research funding from political pressure in the same way that the independence of the Federal Reserve is intended to insulate monetary policy from short-term political interests.
What the Administration Says
OMB has framed the proposed rule as a measure to ensure that taxpayer money is spent in alignment with presidential priorities and consistent with executive branch policy. Administration officials and agency spokespersons have characterized the existing grant-making process as insufficiently accountable to elected officials, and the proposed rule as a correction.
The rule fits within a broader pattern of executive action aimed at reshaping how federal agencies operate — the same approach that has driven new FEMA staffing and operational configurations ahead of this hurricane season and changes to the regulatory and enforcement posture of agencies across the federal government. The administration’s position is that Congress appropriates funds, the president directs how those funds are used within statutory authority, and the peer review process was an administrative convention rather than a legal constraint.
OMB has noted that the proposed rule would not eliminate any funded research program — it would require that grants within those programs receive political approval before they are awarded.
What Researchers and Former Officials Say
The response from the scientific community has been pointed. Scientists, former agency directors, and research university administrators have raised concerns about the practical and strategic consequences of the rule, focusing on several distinct risks.
The first is talent retention and recruitment. Research universities that depend on federal grant funding to employ faculty, graduate students, and postdoctoral researchers are already navigating a difficult environment. A rule that introduces political unpredictability into the grant award process — including the possibility that projects meeting all scientific merit criteria could still be blocked on ideological grounds — creates uncertainty that some leading researchers may respond to by moving abroad or into private-sector research where federal oversight does not apply.
The second is national security research. Federal grants fund a significant share of the basic research that eventually underlies defense applications. Restrictions on international collaboration and uncertainty about the review criteria could disrupt research partnerships with allied nations — the United Kingdom, Japan, South Korea, Germany, France — that have been central to U.S. technological leadership in semiconductors, materials science, and artificial intelligence.
The third is public health. NIH grant funding is the primary mechanism through which the United States develops new treatments, vaccines, diagnostic tools, and public health interventions. The criteria in the proposed rule — blocking research on topics the administration deems inconsistent with executive priorities — could affect not only social science and behavioral research but clinical and biomedical work that touches on population health, where questions of demographic risk and outcomes often implicate the prohibited categories.
Writing in Science, the journal of the American Association for the Advancement of Science, researchers and former agency officials described the rule as a fundamental change in the structure of federally funded science — one that, once implemented, would be difficult to reverse without formal rulemaking.
The Legislative Context
The proposed rule arrives as Congress is negotiating the details of the reconciliation package that has dominated the domestic policy agenda since January. Research agencies are directly affected by both the appropriations levels in that package and the administrative rule changes that the executive branch can implement unilaterally under existing statutory authority.
The OMB rule does not require a congressional vote. It was initiated under the executive’s administrative authority to set uniform federal grant requirements, which derives from statutes including the Federal Grant and Cooperative Agreement Act and the Chief Financial Officers Act. The administration’s position is that this authority is broad enough to encompass the changes in the proposed rule.
Legal scholars are divided on whether the rule as written would survive challenge, particularly on the breadth of the ideological criteria. A rule that blocks grants based on a determination that a research proposal promotes “anti-American values” — a standard with no clear legal definition — faces potential challenge on both statutory and constitutional grounds. Universities and research institutions are expected to use the public comment period to build a record that could support litigation if the rule is finalized as written.
The Timeline and What Comes Next
The public comment period on the proposed rule runs through July 13, 2026. OMB is required under the Administrative Procedure Act to review and respond to significant public comments before finalizing the rule, a process that typically takes several months. If the rule is finalized close to the proposed effective date of October 1, the window for the rule’s opponents to seek a preliminary injunction from a federal court would be narrow.
Several scientific and higher education organizations have already indicated they intend to file formal comments opposing the rule in its current form. The Association of American Universities and the Association of Public and Land-grant Universities — organizations representing major research universities — have convened their legal and policy staff to prepare responses.
For researchers with active grants or pending applications at NIH, NSF, and other agencies, the practical question is what the pre-issuance review process would look like in operation. The rule establishes the authority for political appointee review but does not specify timelines, staffing ratios, or the procedural rights of applicants whose grants are blocked at the review stage. Those details would presumably be specified in agency-level implementation guidance if the rule is finalized.
The comment period is open. Submissions can be filed at regulations.gov under docket OMB-2026-0034.
Sources 6 cited · 1 primary
- Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Financial Assistance — Proposed Rule (Docket OMB-2026-0034)
- President Trump seeks control of science funding
- White House proposes new rules giving political appointees final approval on research grants
- White House seeks to tighten political oversight of grantmaking
- OMB Proposes Rules Establishing Political Oversight of Grants
- How the Trump Administration Plans to Politicize Federal Grants
American Courant cites its sources and links to primary documents where they exist. How we report →
